What is the prevalence of Blastomycosis?

Blastomycosis is an infection caused by the fungus Blastomyces dermatitidis, which is considered an emerging but under-reported disease in endemic regions. While exact global prevalence is unknown due to reporting inconsistencies, the annual incidence is estimated at approximately 1 to 2 cases per 100,000 population in highly endemic areas of North America, though it is frequently misdiagnosed as other respiratory conditions.

What is the geographic distribution of Blastomycosis?

Blastomycosis is primarily endemic to the Ohio and Mississippi River valleys, the Great Lakes region, and parts of Canada. Because the fungus thrives in moist soil and decomposing organic matter, prevalence is highest in these specific geographic zones. It is not considered a communicable disease, meaning it does not spread from person to person, but rather through the inhalation of fungal spores from the environment.

Who is most at risk for Blastomycosis?

While anyone can contract Blastomycosis, certain demographics show higher susceptibility based on environmental exposure and immune status. Clinical data indicates the following patterns regarding disease distribution:

• Gender: Historically, Blastomycosis has been reported more frequently in males, often attributed to higher rates of outdoor occupational or recreational exposure.


• Age: It can affect all age groups, including pediatric patients, but it is most commonly diagnosed in adults between the ages of 30 and 60.


• Immune Status: Individuals with weakened immune systems are at a significantly higher risk of developing severe or disseminated forms of the disease.

Why is accurate data for Blastomycosis challenging to obtain?

Determining the true prevalence of Blastomycosis is difficult because the condition is not nationally reportable in many jurisdictions. Furthermore, Blastomycosis symptoms often mimic bacterial pneumonia, tuberculosis, or lung cancer, leading to frequent misdiagnosis. Within the DiseaseMaps.org community, 27 individuals have shared their experiences, providing a valuable real-world perspective that highlights the diagnostic delays many patients face when navigating Blastomycosis.

Is Blastomycosis considered a rare disease?

In the context of public health, Blastomycosis is often classified as a rare or neglected fungal infection. Because it is geographically localized, it is often overlooked in broader clinical discussions. The rarity of Blastomycosis means that awareness among primary care providers is crucial for early detection and treatment success.

Next steps

• Consult an infectious disease specialist if you reside in an endemic region and have persistent respiratory symptoms.


• Join the DiseaseMaps.org community to connect with others who have navigated the diagnosis and treatment of Blastomycosis.


• Ensure your healthcare provider considers fungal cultures or antigen testing if standard antibiotic treatments for pneumonia fail.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Centers for Disease Control and Prevention (CDC) - Blastomycosis Statistics


• Orphanet: Portal for rare diseases and orphan drugs


• PubMed Central: Epidemiological reviews of endemic mycoses